Shilpa Medicare Ltd's Jadcherla facility gets GMP certification from Russian authorities

Shilpa Medicare Ltd's Finished Dosage Formulation Facility (Sterile and Non-sterile) located at S-20 to S-26, Pharmaceutical Formulations SEZ, TSIIC, Jadcherla, Telangana State, India has been issued GMP certification by Ministry of Industry and Trade of the Russian Federation for the GMP inspection held from 22-02-2021 to 26-02-2021. There were No Critical, Major and Minor observations found during GMP inspection process.

The GMP certificate is valid for three years until April 2024.

Shares of SHILPA MEDICARE LTD. was last trading in BSE at Rs.517.8 as compared to the previous close of Rs. 515.9. The total number of shares traded during the day was 34809 in over 1292 trades.

The stock hit an intraday high of Rs. 528.05 and intraday low of 512.55. The net turnover during the day was Rs. 18044340.

Source : Equity Bulls

Keywords